Decibel Cannabis Co Inc DB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DB is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CAD 0.13
- Day Range
- CAD 0.13–0.14
- 52-Week Range
- CAD 0.10–0.19
- Bid/Ask
- CAD 0.13 / CAD 0.14
- Market Cap
- CAD 53.18 Mil
- Volume/Avg
- 64,554 / 198,746
Key Statistics
- Price/Earnings (Normalized)
- 5.47
- Price/Sales
- 0.48
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Decibel Cannabis Co Inc is engaged in the cannabis operations business. It is involved in the production, distribution, and sale of recreational cannabis. All the revenues are generated in Canada. The company's revenue is comprised of wholesale sales of both products and services through its production facilities to distributors and licensed cannabis producers as well as the direct sale of products through its retail locations to end customers.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 171
- Website
- https://www.decibelcc.com
Valuation
|
Metric
|
DB
|
|---|---|
Price/Earnings (Normalized) | 5.47 |
Price/Book Value | 1.17 |
Price/Sales | 0.48 |
Price/Cash Flow | 3.70 |
Price/Earnings
DB
Financial Strength
|
Metric
|
DB
|
|---|---|
Quick Ratio | 0.41 |
Current Ratio | 1.26 |
Interest Coverage | −0.35 |
Quick Ratio
DB
Profitability
|
Metric
|
DB
|
|---|---|
Return on Assets (Normalized) | 0.29% |
Return on Equity (Normalized) | 0.93% |
Return on Invested Capital (Normalized) | 3.31% |
Return on Assets
DB
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Hckvnvtlr | Yfvh | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Fzwzlmcs | Mfqylw | $70.8 Bil | |
HLN
| Haleon PLC ADR | Qpvjwnmz | Rhrc | $38.2 Bil | |
VTRS
| Viatris Inc | Dtsdvhg | Qqlym | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ykgvwysl | Ddbm | $12.5 Bil | |
CTLT
| Catalent Inc | Lmspjdkp | Lpgbl | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Rvhbjjzq | Fgxr | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Csqqdwnz | Lspp | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jjsynbzmk | Prbjxt | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Klqbbhsjz | Gsw | $2.9 Bil |